New diabetes clinical trial: Effect of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Stimulation on Smoking Consumption in Type 2 Diabetes Patients

Published on: April 10, 2025 at 11:00PM
Conditions: Diabetes Mellitus, Type 2; Nicotine Dependence, Cigarettes
Interventions: Drug: Application of GLP-1RAs drugs; Drug: DPP-4i group
Sponsors: Shanghai East Hospital
Enrolling by invitation
https://ift.tt/Jw1lHQX